LYPLA1 and breast carcinoma: Figure 7E showed the ROC curves for patients’ survival at 2, 4, and 5 years, indicating that LYPLA1 expression accurately predicted 2-, 4-, and 5-year survival rates in patients with breast cancer (AUC = 0.753, 0.850, and 0.869).